logo
UN fears HIV infections will soar after US cuts funding

UN fears HIV infections will soar after US cuts funding

Yahoo24-03-2025

Daily new HIV infections around the world could almost double without the aid provided by the United States, the UN programme for combatting HIV and AIDS (UNAIDS), said in Geneva on Monday.
Executive director Winnie Byanyima expressed understanding for the desire of the United States to cut back its funding for aid projects around the world, but an abrupt withdrawal by the US would have devastating consequences, she said. No other donors had thus far indicated that they would cover the loss.
Many African governments were working to boost contributions to health care, she noted, but that can't happen immediately.
Byanyima put the UNAIDS budget for 2024 at $220 million, more than half of which had been funded by the US.
Thousands of HIV-infected people were no longer receiving medication as a result of the US cutback, and without reliable care, the virus could spread rapidly again, she said.
Over the next four years, 8.7 million new infections and 6.3 million additional deaths could occur without US funds, according to UNAIDS projections.
Byanyima said that US President Donald Trump could conclude a good deal by allowing the US company Gilead to distribute its medication to at-risk individuals, thereby making a large profit.
UNAIDS put the number of new HIV infections in 2023 at 1.3 million around the world, and the number of deaths from AIDS complications at 600,000. Byanyima called on the US administration to resume funding as soon as possible.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CVS responds to Gov. Sanders' New York Times Op-Ed about PBMs
CVS responds to Gov. Sanders' New York Times Op-Ed about PBMs

Yahoo

timean hour ago

  • Yahoo

CVS responds to Gov. Sanders' New York Times Op-Ed about PBMs

FAYETTEVILLE, Ark. (KNWA/KFTA) — CVS Health is ramping up its campaign against a new Arkansas law that targets pharmacy benefit managers, publicly clashing with Gov. Sarah Huckabee Sanders just hours after she defended the legislation in a guest essay for The New York Times. Act 624, signed by Sanders in April, bars companies from running both a pharmacy and a pharmacy benefit manager (PBM), a model used by CVS. PBMs manage prescription drug benefits for insurers, negotiate prices with drug manufacturers and reimburse pharmacies. In her guest essay on June 10, Sanders wrote that PBMs 'forcibly steer patients away from independent operators' and inflate drug prices. She also wrote that Act 624 lets PBMs keep operating in Arkansas, but, she said, 'they just can't continue to mistreat patients and box out other pharmacies.' Sanders claimed the three largest pharmacy benefit managers handle 80% of U.S. prescriptions and earn 70% of specialty drug revenue through their affiliated pharmacies. 'Now, CVS is threatening to close down every pharmacy it operates in our state — preferring to take its ball and go home rather than divest from its pharmacy benefit management business and actually serve the patients it claims to care about,' Sanders wrote. CVS sues Arkansas over new pharmacy law CVS issued a statement later that day disputing Sanders' characterization of the law, claiming that the new law is about 'choosing winners and losers and rewarding special interests.' 'Out-of-state competitors are disadvantaged,' a CVS spokesperson said. 'In-state competitors, including Walmart, would handsomely benefit from the closures of pharmacies owned by us and others. The losers are the people of Arkansas who will pay more.' CVS says the law could force it to close 23 pharmacies in Arkansas, affecting 340,000 patients, and block its specialty pharmacy from treating 10,000 high-risk patients with cancer, HIV and rare diseases. The company is also challenging Act 624 in federal court, arguing it violates the U.S. Constitution. 'PBMs are the last line of defense between drugmakers that want to charge a lot of money, and the American businesses, unions, health plans, and government agencies that want to provide good benefits to people,' CVS said in its response on June 10. CVS argues the law is unconstitutional because it unfairly targets out-of-state businesses, treats similar companies differently, and conflicts with federal laws like ERISA and Medicare rules. The company also raised concerns about potential conflicts of interest. 'One state representative who co-sponsored this law owns 13 pharmacies by himself,' the company said, linking to state Rep. Brandon Achor's campaign website. Act 624, introduced as House Bill 1150, was backed by the Arkansas Pharmacists Association and Attorney General Tim Griffin, and passed easily. Act 624 is scheduled to take effect January 1, 2026. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More at-home health tests are now available. How to know what's right for you
More at-home health tests are now available. How to know what's right for you

Associated Press

time4 hours ago

  • Associated Press

More at-home health tests are now available. How to know what's right for you

The doctor is in — the mailbox, that is. You can now do self-administered tests for everything from thyroid function to HIV in the privacy of your own home — and that list continues to grow, as the Food and Drug Administration recently approved the first at-home cervical cancer test. While the tests can make it easier for people to access health care and can be helpful for those who have extreme anxiety about sensitive or invasive medical exams, experts warn that most of the tests cannot replace an actual in-person visit. Here's what doctors say you can test for at home, and when you should make the trek to your physician's office. What kinds of at-home tests are available? There are two kinds at 'at-home tests.' In one type, the patient collects the sample and sends it off to a lab; the new cervical cancer test is like this. The other gives an instant result — think COVID-19 and pregnancy tests. What are the benefits of at-home tests? HIV home-testing kits can improve rates of diagnosing sexually transmitted infections in rural communities and help people who are nervous about going to the doctor to seek a sensitive test, said Dr. Joseph Cherabie, an infectious diseases specialist in St. Louis. 'You really want to get people to care as quickly as possible, but some people could be very anxious about that results as well,' Cherabie said. 'And they have very negative reactions.' Labs are required to report a positive HIV test, instead of putting the onus on the patient who took the test, Cherabie said, and and, often, the patient is matched up with HIV support services. 'If you are part of a sexual and gender minority community, going to a doctor's office can be full of a lot of historical trauma, and you may prefer to just do testing at home without anyone judging you or asking you invasive questions about your sex life,' Cherabie said. The new cervical cancer test — which tests for strains of human papillomavirus, or HPV — involves a testing swab that's like a tampon, said Dr. Susan Modesitt, a gynecologic oncologist at Emory University in Atlanta. It is not, Modesitt said, a replacement for a Pap smear, the exam in which a metal speculum is inserted in the vagina to scrape cervix cells. A doctor's visit also involves a pelvic exam, a chance to talk about abnormal bleeding — a sign of endometrial cancer — and other symptoms and issues, like menopause or STIs. 'There are so many other reasons to see your doctor and get an exam outside of a cervical cancer screening,' she said. The at-home cervical cancer test from Teal Health requires a prescription, and the company said that results are not left for the patient to interpret. I live in a rural area — can I take an at-home test? Some at-home tests can replace a trip to the doctor's office. That's especially true in rural areas, where it can be difficult to get a colonoscopy. 'The colonoscopy requires a pre-op, and you have to drive maybe 70 miles for it,' said Dr. Steven Furr, board chair of the American Academy of Family Physicians who practices in rural Alabama. 'You get anesthesia. It's actually almost like a surgical procedure in many ways. 'So, for a lot of people, that's pretty arduous. That's where an at-home test can come in handy.' But, Furr said, if your test reveals issues, you need to go to your doctor. Plus, patients should always discuss test results with their physician instead of interpreting them on their own, he said. Who shouldn't do at-home tests? If you have symptoms of what you're testing for, go to the doctor. At-home colon cancer tests aren't the right option for people with a history of colon cancer or high-risk conditions, such as inflammatory bowel disease, said Dr. Zachariah Foda, a gastroenterologist at Johns Hopkins. He added that they're also not recommended for people who are having GI symptoms. While there are tests for many things — running anywhere from $15 to $400, depending on what is being evaluated — Furr said it's essential to make sure that your test is FDA-approved so you can better trust the results. 'Anytime we get people involved in their own health care and help them understand what's going on, I think that's a good thing and it gives us a chance to talk,' he said. 'Any kind of screening is better than no screening.' ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

House votes to cut global health funding
House votes to cut global health funding

The Hill

time5 hours ago

  • The Hill

House votes to cut global health funding

The Big Story The House on Thursday narrowly passed a 'recissions' proposal to cancel $9.4 billion in money Congress already appropriated, including $900 million in funding for global health initiatives. Four Republicans voted against it. © AFP via Getty The vote codifies cuts championed by the Department of Government Efficiency, which was led by billionaire Elon Musk. It includes slashing $500 million of the $6 billion appropriated in fiscal year 2025 for global health programs like the President's Emergency Plan for AIDS Relief (PEPFAR) that are within the Department of State and $400 million of the $4 billion appropriated for USAID global health programs. Included in that plan is ending all funding for Gavi, a global program that purchases shots to help vaccinate children in developing countries against some of the world's deadliest diseases. PEPFAR is seen as one of the most successful U.S.-led international aid programs and has typically enjoyed bipartisan support. It's credited with having saved 26 million lives and enabling 7.8 million babies to be born without HIV infection. Global health experts and proponents of PEPFAR have said the cuts will have a devastating impact on HIV/AIDS prevention and treatment. It would endanger access to lifesaving antiretroviral medication and put millions of children and adults at risk. The White House wants to phase down its investment in PEPFAR and have other countries absorb most of the cost. 'It is something that our budget will be very trim on because we believe that many of these nonprofits are not geared toward the viewpoints of the administration, and we're $37 trillion in debt,' White House budget director Russ Vought told appropriators last week. 'So, at some point, the continent of Africa needs to absorb more of the burden of providing this health care.' Advocates agree the program wasn't meant to last forever, but the groundwork hasn't been done to make sure PEPFAR can be transitioned successfully. The White House plan would cut off funding without a plan. But the Senate will have the final say on how sweeping the clawbacks are. Congress has 45 days to act, and not every Republican senator is on board. Senate Appropriations Committee chair Susan Collins (R-Maine) has said she is opposed to PEPFAR cuts, and others have expressed concern about the other funding cuts in the package, like public broadcasting programs. Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel, Joseph Choi and Alejandra O'Connell-Domenech — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads How policy will be impacting the health care sector this week and beyond: Prenatal exposure to 'forever chemicals' may raise blood pressure during teen years: Study Humans exposed to toxic 'forever chemicals' before birth may exhibit higher blood pressure during their teenage years, a new study has found. This connection was particularly pronounced in boys and in children born to non-Hispanic Black mothers, scientists observed in the study, published Thursday in the Journal of the American Heart Association. While previous research has shown these synthetic compounds may affect a rapidly … CDC backtracks, will rehire more than 450 people it laid off The Centers for Disease Control and Prevention (CDC) is rehiring about 460 employees who had previously been laid off, according to an email notice reviewed by The Hill. The Department of Health and Human Services (HHS) confirmed on Thursday that reinstatement notices were sent but provided few other details. 'The Trump Administration is committed to protecting essential services—whether it's supporting coal … Trump's former surgeon general rips RFK Jr.'s purge of vaccine board President Trump's former surgeon general blasted Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to fire the entirety of a federal advisory committee on vaccine guidance, saying the move jeopardizes public health and threatens public trust in health institutions. In an op-ed published by Time, former Surgeon General Jerome Adams wrote that Kennedy's recent actions cast doubt over his pledge … In Other News Branch out with a different read: Cassidy in a bind as RFK Jr. blows up vaccine policy Health and Human Services Secretary Robert F. Kennedy Jr. has put Sen. Bill Cassidy (R-La.) in a political bind, squeezed by his loyalty to President Trump and commitment to medicine. Cassidy, the chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, publicly wavered over Kennedy's confirmation, sharply criticizing his views before eventually voting for him. Cassidy said he secured a series … Around the Nation Local and state headlines on health care: What We're Reading Health news we've flagged from other outlets: What Others are Reading Most read stories on The Hill right now: Republicans lay groundwork for 'total tax cliff' at end of Trump's term Congressional Republicans are laying the groundwork for a tax cliff at the end of President Trump's term in office. While the conference is pushing … Read more Padilla forcibly removed from Noem press conference, handcuffed Sen. Alex Padilla (D-Calif.) was forcibly removed and then handcuffed after he interrupted a press conference Homeland Security Secretary Kristi Noem … Read more What People Think Opinion related to health submitted to The Hill: You're all caught up. See you tomorrow! Thank you for signing up! Subscribe to more newsletters here

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store